Abstract:Objective: The aim of this research is to synthesize and evaluate beta-amyloid (A beta) binding probes for early diagnosis of Alzheimer's disease (AD). Methods: We designed and synthesized two new fluorine tag Indanone derivatives (compounds a and b), and then based on the platform of ultra-high-performance liquid chromatography-mass spectrometry for its affinity with beta-amyloid (A beta) protein determination, and use of compounds a and b solution as dyes for AD brain tissue staining in vitro. To evaluate the lipid solubility and stability of the drug, the lipid-water partition coefficient was determined using n-octanol as the lipid phase, and the stability of compound b was tested in vitro to mimic the in vivo environment. Results: Both compounds a and b exhibit high affinity for binding to A beta. The Kd values of compound a for A beta 1-40 and A beta 1-42 were found to be 467.40 +/- 63.26, and 227.57 +/- 19.08 nmol/L, respectively. Similarly, the Kd values of compound b for A beta 1-40 and A beta 1-42 were 438.13 +/- 26.77 and 167.27 +/- 23.70 nmol/L, respectively. In the staining experiment of human brain slices of AD, both compounds a and b were found to bind to A beta plaques, and their staining effect was stronger than positive control (0.1 % ThS). In the lipid-water partition coefficient experiment, compound a and compound b exhibited logP values of 0.84 and 1.85, respectively, indicating good lipid solubility. In the in vitro stability experiment, compound b exhibited a concentration of 74.79 %, 80.47 %, and 70.00 % after incubation in liver, brain homogenate, and blood, respectively. Conclusion: We have successfully designed and synthesized two probes labeled with fluoride that can be used for diagnosing AD. These probes have a high affinity for A beta protein and good lipid solubility. As A contrast agent based on A beta protein, compound b showed greater potential than compound a.

Novel Indanone Derivatives As Potential Imaging Probes for Β‐amyloid Plaques in the Brain

6-Methoxy-indanone Derivatives As Potential Probes for Β-Amyloid Plaques in Alzheimer's Disease

Novel Imaging Agents for Β-Amyloid Plaque Based on the N-benzoylindole Core.

Novel Anilinophthalimide Derivatives As Potential Probes for Beta-Amyloid Plaque in the Brain

Multi‐fluorine Labeled Indanone Derivatives As Potential MRI Imaging Probes for Β‐amyloid Plaques

Synthesis and in Vitro Evaluation of Novel Indanone Derivatives Targeting Β-Amyloid

(E)-5-Styryl-1h-Indole And (E)-6-Styrylquinoline Derivatives Serve As Probes For Beta-Amyloid Plaques

Radioiodinated Benzimidazole Derivatives As Single Photon Emission Computed Tomography Probes for Imaging of Β-Amyloid Plaques in Alzheimer's Disease

Naphthofuran Derivatives As Potential Imaging Agents for Β-Amyloid Plaques in the Brain

Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for β-amyloid plaques in Alzheimer’s disease

Novel Indole Derivatives as Potential Imaging Agents for Alzheimer's Disease

Novel Quinoxaline Derivatives for in Vivo Imaging of Β-Amyloid Plaques in the Brain.

Novel ¹⁸F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.

Novel pyrrolidine-alkylamino-substituted dicyanoisophorone derivatives as near-infrared fluorescence probe for imaging β-amyloid in vitro and in vivo

Synthesis and Biological Evaluation of 18F-Labled 2-Phenylindole Derivatives As PET Imaging Probes for Β-Amyloid Plaques

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits

QSAR Study of 125I-Labeled 2-(4-aminophenyl)benzothiazole Derivatives As Imaging Agents for Β-Amyloid in the Brain with Alzheimer’s Disease

Synthesis and Biological Evaluation of Indole-Chalcone Derivatives As Β-Amyloid Imaging Probe

Novel 18F-Labeled Benzoxazole Derivatives As Potential Positron Emission Tomography Probes for Imaging of Cerebral Β-Amyloid Plaques in Alzheimer’s Disease

A hemicyanine derivative for near-infrared imaging of β-amyloid plaques in Alzheimer's disease.

Radiolabeled Bioactive Benzoheterocycles for Imaging Beta-Amyloid Plaques in Alzheimer'S Disease